All Blogs

Dec 31, 2025

Spondylolisthesis, a formidable spinal condition characterized by the slippage of one vertebra over the one below it, represents a significant global health burden. It is a source of chronic, debilitating low back pain, neurological deficits, and reduced quality of life for millions. Historically, the management of...

Dec 24, 2025

In the intricate landscape of healthcare, maintaining optimal nutritional status is fundamental to recovery, chronic disease management, and overall patient well-being. For millions globally who cannot ingest, digest, or absorb nutrients via the conventional gastrointestinal route, an alternative lifeline is requir...

Dec 18, 2025

BD Expanded BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec  On December 15, 2025, BD (Becton, Dickinson and Company), a leading global medical technology company, announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics po...

Dec 26, 2025

The pharmaceutical landscape for HER2-positive metastatic breast cancer has undergone a significant transformation with the FDA's approval of ENHERTU (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab as a first-line treatment—marking the first new therapeutic option approved in more than a decade for...

Dec 22, 2025

Chimeric Antigen Receptor T-cell (CAR-T) therapy has established itself as one of the most disruptive innovations in modern medicine. Since the first approval in 2017, CAR-T therapies have transformed outcomes in hematologic malignancies, achieving deep, durable remissions in patient populations previously resistan...

Dec 17, 2025

Artificial intelligence (AI) has rapidly emerged as a transformative force in medical imaging, revolutionizing disease detection, diagnosis, and monitoring. From radiology to pathology, AI algorithms are enhancing image interpretation, improving diagnostic accuracy, and streamlining clinical workflows across health...

Dec 29, 2025

Leptomeningeal metastases, also known as leptomeningeal disease, carcinomatous meningitis, or neoplastic meningitis, represent a serious complication of advanced cancer in which malignant cells spread through the cerebrospinal fluid (CSF) to infiltrate the protective membranes surrounding the brain and spinal cord....

Dec 19, 2025

In a landmark decision on December 10, 2025, the FDA approved WASKYRA (etuvetidigene autotemcel), marking a transformative milestone in the treatment of Wiskott-Aldrich syndrome—a rare, life-threatening genetic blood disorder. This approval represents not only a significant advancement in gene therapy but also a hi...

Dec 16, 2025

Pilatus Biosciences Receives FDA IND Clearance for PLT012, a Novel Anti-CD36 Metabolic Checkpoint Antibody Pilatus Biosciences has announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for PLT012, a first-in-class, humanized anti-CD36 monoclonal ant...

Dec 15, 2025

Cushing’s disease is a rare but serious endocrine disorder caused by a pituitary adenoma that leads to excessive secretion of ACTH. This condition results in abnormally high cortisol levels in the body, causing a cascade of serious health complications. Cushing’s syndrome, the clinical manifestation of this disorde...